Key stats
About GF FUND MANAGEMENT
Home page
Inception date
Jun 25, 2015
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
GF Fund Management Co., Ltd.
ISIN
CNE1000037V8
The Fund mainly invests in listed companies in pharmaceutical-related industries. Through bottom-up in-depth mining and selection of individual stocks, Strive to obtain returns for fund share holders that exceed performance comparison benchmarks.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
No, 159944 doesn't pay dividends to its holders.
159944 shares are issued by GF Securities Co., Ltd. under the brand GF Fund. The ETF was launched on Jun 25, 2015, and its management style is Passive.
159944 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159944 follows the CSI All-Share Raw Materials Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.